This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Ischemaview, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Val Smiricinschi in Aneurysm Detection
Introduction
Val Smiricinschi is an accomplished inventor based in Scottsdale, AZ (US). He has made significant contributions to the field of medical technology, particularly in the detection and monitoring of aneurysms. With a total of 2 patents, his work is paving the way for advancements in healthcare.
Latest Patents
Val Smiricinschi's latest patents include innovative systems and methods for analytical detection of aneurysms. The first patent describes a method that involves forming a virtual skeleton model, which consists of multiple edges and skeleton points associated with blood vessel surface points. This method allows for the identification of potential aneurysms by virtually fitting elliptically shaped tubules for each edge of the model. The second patent focuses on analytical comparison and monitoring of cerebral aneurysms. It details a process of forming two virtual skeleton models from different image segmentations and identifying growth in aneurysms by overlapping these models.
Career Highlights
Val Smiricinschi is currently employed at Ischemaview, Inc., where he continues to develop groundbreaking technologies in the medical field. His expertise in analytical detection systems has positioned him as a key player in the advancement of aneurysm detection methods.
Collaborations
Throughout his career, Val has collaborated with talented individuals such as Kristen Catherine Karman-Shoemake and Mohamed Haithem Babiker. These partnerships have contributed to the innovative solutions he has developed.
Conclusion
Val Smiricinschi's work in the field of aneurysm detection exemplifies the impact of innovation in healthcare technology. His patents reflect a commitment to improving patient outcomes through advanced analytical methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile